Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first-line combination antiretroviral therapy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first-line combination antiretroviral therapy
Authors
Keywords
-
Journal
HIV MEDICINE
Volume 16, Issue 9, Pages 553-562
Publisher
Wiley
Online
2015-05-06
DOI
10.1111/hiv.12257
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study
- (2014) Suhaib Hattab et al. BMC INFECTIOUS DISEASES
- Soluble Markers of Inflammation and Coagulation but Not T-Cell Activation Predict Non–AIDS-Defining Morbid Events During Suppressive Antiretroviral Treatment
- (2014) Allan R. Tenorio et al. JOURNAL OF INFECTIOUS DISEASES
- Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection
- (2014) Peter W. Hunt et al. JOURNAL OF INFECTIOUS DISEASES
- HIV-1 infection induces strong production of IP-10 through TLR7/9-dependent pathways
- (2013) Rachel P. Simmons et al. AIDS
- Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection
- (2013) Chris T. Longenecker et al. AIDS
- The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case–control study
- (2013) Andrea De Luca et al. BMC INFECTIOUS DISEASES
- CD8+ T-Cell Activation in HIV-1–Infected Patients Experiencing Transient Low-level Viremia During Antiretroviral Therapy
- (2013) Babafemi Taiwo et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Associations of Inflammatory Markers With AIDS and Non-AIDS Clinical Events After Initiation of Antiretroviral Therapy
- (2013) Grace A. McComsey et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Associations of T cell activation and inflammatory biomarkers with virological response to darunavir/ritonavir plus raltegravir therapy
- (2013) B. Taiwo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs
- (2013) Christine Katlama et al. LANCET
- Immune Activation in HIV-Infected Aging Women on Antiretrovirals—Implications for Age-Associated Comorbidities: A Cross-Sectional Pilot Study
- (2013) Maria L. Alcaide et al. PLoS One
- Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir
- (2012) Grace A. McComsey et al. AIDS
- Markers of microbial translocation and risk of AIDS-related lymphoma
- (2012) Morgan A. Marks et al. AIDS
- Magnitude of Virologic Blips Is Associated With a Higher Risk for Virologic Rebound in HIV-Infected Individuals: A Recurrent Events Analysis
- (2012) J. Troy Grennan et al. JOURNAL OF INFECTIOUS DISEASES
- Microbial translocation in HIV infection: causes, consequences and treatment opportunities
- (2012) Netanya G. Sandler et al. NATURE REVIEWS MICROBIOLOGY
- A Plasma Biomarker Signature of Immune Activation in HIV Patients on Antiretroviral Therapy
- (2012) Anupa Kamat et al. PLoS One
- Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals
- (2012) Daniel A. Duprez et al. PLoS One
- Acute Plasma Biomarkers of T Cell Activation Set-Point Levels and of Disease Progression in HIV-1 Infection
- (2012) Anne-Sophie Liovat et al. PLoS One
- Microbial translocation, immune activation, and HIV disease
- (2012) Nichole R. Klatt et al. TRENDS IN MICROBIOLOGY
- CD4 count at presentation for HIV care in the United States and Canada: Are those over 50 years more likely to have a delayed presentation?
- (2012) Keri N Althoff et al. AIDS Research and Therapy
- Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients
- (2011) Victor Appay et al. AIDS
- The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women
- (2011) Sheila M. Keating et al. AIDS
- Epstein-Barr Virus load and immune activation in Human Immunodeficiency Virus type 1-infected patients
- (2011) Maria Raffaella Petrara et al. JOURNAL OF CLINICAL VIROLOGY
- Valganciclovir Reduces T Cell Activation in HIV-Infected Individuals With Incomplete CD4+ T Cell Recovery on Antiretroviral Therapy
- (2011) Peter W. Hunt et al. JOURNAL OF INFECTIOUS DISEASES
- Higher Levels of CRP, D-dimer, IL-6, and Hyaluronic Acid Before Initiation of Antiretroviral Therapy (ART) Are Associated With Increased Risk of AIDS or Death
- (2011) David R. Boulware et al. JOURNAL OF INFECTIOUS DISEASES
- Immunologic Failure Despite Suppressive Antiretroviral Therapy Is Related to Activation and Turnover of Memory CD4 Cells
- (2011) Michael M. Lederman et al. JOURNAL OF INFECTIOUS DISEASES
- Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
- (2011) Netanya G. Sandler et al. JOURNAL OF INFECTIOUS DISEASES
- Inflammatory biomarkers and abacavir use in the Womenʼs Interagency HIV Study and the Multicenter AIDS Cohort Study
- (2010) Frank J Palella et al. AIDS
- Persistent Microbial Translocation and Immune Activation in HIV‐1–Infected South Africans Receiving Combination Antiretroviral Therapy
- (2010) Edana Cassol et al. JOURNAL OF INFECTIOUS DISEASES
- Effects of Maraviroc and Efavirenz on Markers of Immune Activation and Inflammation and Associations with CD4+ Cell Rises in HIV-Infected Patients
- (2010) Nicholas Funderburg et al. PLoS One
- Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment
- (2009) Kimberly Y Smith et al. AIDS
- HIV-1 Residual Viremia Correlates with Persistent T-Cell Activation in Poor Immunological Responders to Combination Antiretroviral Therapy
- (2009) Maud Mavigner et al. PLoS One
- Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review
- (2008) John Danesh et al. PLOS MEDICINE
- Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
- (2008) Lewis H Kuller et al. PLOS MEDICINE
- Relationship between T Cell Activation and CD4+T Cell Count in HIV‐Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy
- (2007) Peter W. Hunt et al. JOURNAL OF INFECTIOUS DISEASES
- Immune activation and inflammation in HIV-1 infection: causes and consequences
- (2007) V Appay et al. JOURNAL OF PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started